---
title: "Will the FDA approve retatrutide? — retatrutide (LY3437943)"
canonical_url: https://betcrypto.now/events/will-the-fda-approve-retatrutide-retatrutide-ly3437943
status: live
trading_closes_at: 2029-01-01T04:59:00+00:00
total_volume_usd: 50390.63
venues: ["Kalshi"]
categories: []
prices_as_of: 2026-10-09T13:22:04+00:00
publisher: BetCrypto
data_api: https://betcrypto.now/api/v1/events/will-the-fda-approve-retatrutide-retatrutide-ly3437943
---

# Will the FDA approve retatrutide? — retatrutide (LY3437943)

Live · $50,391 traded · listed on Kalshi

## Main market

| Outcome | Probability | Cheapest | Kalshi |
|---|---|---|---|
| Before Jan 1, 2028 | 86% | 86¢ on Kalshi | 86¢ |
| Before Jul 1, 2027 | 29% | 31¢ on Kalshi | 31¢ |
| Before Jan 1, 2027 | 4% | 4¢ on Kalshi | 4¢ |
| Before Jan 1, 2029 | — | — | — |
| Before Jul 1, 2028 | — | — | — |

## Open on a venue

- [Kalshi](https://betcrypto.now/go/e/293350?via=md)

---

Probability is the cross-venue consensus (book midpoints, 0–100%). Venue columns are what buying costs there (the ask). Prices move constantly; re-check at the canonical URL or https://betcrypto.now/api/v1/events/will-the-fda-approve-retatrutide-retatrutide-ly3437943.

BetCrypto is an odds-comparison and information service. It accepts no wagers and gives no betting or financial advice; prediction-market availability depends on where you live.